[Resolution of organic stone constituents in kidney stone chemolysis].
D000111:Acetylcysteine / Q000494:pharmacology; D001777:Blood Coagulation; D001963:Bromelains / Q000494:pharmacology; D002918:Chymotrypsin / Q000494:pharmacology; D003851:Deoxyribonucleases / Q000494:pharmacology; D003902:Detergents / Q000494:pharmacology; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000187:drug effects*; D005341:Fibrinolysin / Q000494:pharmacology; D005601:Framycetin / Q000494:pharmacology; D006801:Humans; D007669:Kidney Calculi / Q000188:drug therapy*; D010206:Papain / Q000494:pharmacology; D010434:Pepsin A / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D011422:Propionates / Q000494:pharmacology; D013299:Streptodornase and Streptokinase / Q000494:pharmacology; D013300:Streptokinase / Q000494:pharmacology; D013431:Sulfates; D013501:Surface-Active Agents / Q000627:therapeutic use*; D014357:Trypsin / Q000494:pharmacology
D003902:Detergents; D011422:Propionates; D013431:Sulfates; D013501:Surface-Active Agents; D005601:Framycetin; D001963:Bromelains; D013299:Streptodornase and Streptokinase; D003851:Deoxyribonucleases; D010447:Peptide Hydrolases; D013300:Streptokinase; D002918:Chymotrypsin; D014357:Trypsin; D005341:Fibrinolysin; D010206:Papain; D010434:Pepsin A; D000111:Acetylcysteine
Die Auflösung organischer Steinanteile bei der Nierensteinchemolyse.